124 related articles for article (PubMed ID: 1353661)
21. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study.
Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G
Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the acidity index and integrated intragastric acidity in 645 patients presenting with gastroesophageal reflux disease symptoms.
Blonski WC; Shih GL; Brensinger CM; Katzka DA; Metz DC
Scand J Gastroenterol; 2006 Apr; 41(4):382-9. PubMed ID: 16635904
[TBL] [Abstract][Full Text] [Related]
23. [Effect of octreotide on intragastric pH in patients with duodenal ulcer bleeding].
Nie Y; Li Y; Sha W; Dai S; She Q; Wu H
Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):520-2. PubMed ID: 11809113
[TBL] [Abstract][Full Text] [Related]
24. Comparative effects of two cimetidine regimens on 24-hour intragastric acidity in patients with asymptomatic duodenal ulcer.
Mahachai V; Walker K; Jamali F; Navert H; Cook D; Symes A; Thomson AB
Clin Ther; 1984; 6(3):259-81. PubMed ID: 6373006
[TBL] [Abstract][Full Text] [Related]
25. 24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring.
Savarino V; Mela GS; Zentilin P; Sumberaz A; Bonifacino G; Gambaro P; Celle G
Hepatogastroenterology; 1991 Aug; 38(4):299-301. PubMed ID: 1937375
[TBL] [Abstract][Full Text] [Related]
26. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
[TBL] [Abstract][Full Text] [Related]
27. Twenty-four-hour intragastric pH-metry: evidence of nightly gastric alkalinization in subjects with and without active duodenal ulcer.
Bianco A; Castrucci G; Cagossi M; Greco AV
Riv Eur Sci Med Farmacol; 1992; 14(4):221-8. PubMed ID: 1305995
[TBL] [Abstract][Full Text] [Related]
28. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
29. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
[TBL] [Abstract][Full Text] [Related]
30. Prolonged gastric pH monitoring in responder and nonresponder duodenal ulcer patients: response to placebo and to H2-blocker administration.
Masoero G; Rossanino A; Arossa W; De la Pierre M
J Clin Gastroenterol; 1991 Jun; 13(3):291-5. PubMed ID: 1676715
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of 24-hour gastric pH in normal controls and patients with duodenal ulcer or atrophic gastritis].
Pestiaux A; Ooghe P; Van Cauter J; Henry JP; Ligny G
Gastroenterol Clin Biol; 1990; 14(5):423-7. PubMed ID: 2365174
[TBL] [Abstract][Full Text] [Related]
32. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H
J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516
[TBL] [Abstract][Full Text] [Related]
33. The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients.
Savarino V; Mela GS; Zentilin P; Mele MR; Vigneri S; Mansi C; Celle G
Aliment Pharmacol Ther; 1996 Jun; 10(3):367-72. PubMed ID: 8791965
[TBL] [Abstract][Full Text] [Related]
34. [Acid-related pathology and prolonged continuous gastric pH monitoring. Physiopathologic findings and therapeutic implications].
Celle G; Savarino V; Mela GS
Recenti Prog Med; 1989 Sep; 80(9):485-92. PubMed ID: 2574489
[TBL] [Abstract][Full Text] [Related]
35. Diurnal variation in intragastric pH in children with and without peptic ulcers.
Nagita A; Amemoto K; Yoden A; Aoki S; Sakaguchi M; Ashida K; Mino M
Pediatr Res; 1996 Oct; 40(4):528-32. PubMed ID: 8888278
[TBL] [Abstract][Full Text] [Related]
36. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
[TBL] [Abstract][Full Text] [Related]
37. Tolerance and rebound to H2-receptor antagonists: intragastric acidity in patients with duodenal ulcer.
Wilder-Smith CH; Halter F; Merki HS
Dig Dis Sci; 1991 Dec; 36(12):1685-90. PubMed ID: 1748035
[TBL] [Abstract][Full Text] [Related]
38. 24-hour intragastric pH: continuous monitoring or nasogastric aspiration?
Reynolds JR; Walt RP; Hardcastle JD; Clark AG; Smart HL; Langman MJ
Digestion; 1986; 33(4):219-24. PubMed ID: 3956889
[TBL] [Abstract][Full Text] [Related]
39. Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring.
Savarino V; Mela GS; Zentilin P; Sumberaz A; Cutela P; Celle G
Digestion; 1991; 48(3):141-8. PubMed ID: 1916034
[TBL] [Abstract][Full Text] [Related]
40. A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer.
Vigneri S; Savarino V; Mela GS; Termini R; Di Mario F; Pantalena M; Zentilin P; Muratore F; Scialabba A; Badalamenti S
Scand J Gastroenterol; 1994 Jun; 29(6):488-92. PubMed ID: 8079104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
